You are here

N1 -
Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan

Event Time:

Sunday May 5, 2019 3:30 pm to 5:30 pm

Topic(s):

Child Neurology and Developmental Neurology, Movement Disorders

Director(s):

Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN

Description:

This Neuroscience in the Clinic session is organized in partnership with the Movement Disorders Society and is designed to bring cutting-edge scientific research together with clinical application. This program will feature invited speakers as well as abstract presentations, and will conclude with a panel discussion. This session will focus on emerging knowledge in the underlying pathophysiology of the epilepsy-movement disorder spectrum of genetic diseases, with clinical correlation related to diagnosis and treatment. The discussion will address salient features of this group of disorders from infancy to adulthood and implications for diagnosis and treatment.

Completion Message:

Attendees will become familiar with updates in recent gene discovery in disorders spanning the epilepsy-movement disorder spectrum and a pathophysiological framework for understanding synaptopathies, channelopathies, and transportopathies as a cause of epilepsies and movement disorders.

Clinical Features and Diagnosis in Epilepsy-Movement Disorder Overlap Syndromes

Erika Fullwood Augustine MD, FAAN

5:15 PM - 5:30 PM

Panel Discussion

Faculty

Disclosures

Speaker

Disclosure

Erika Fullwood Augustine, MD, FAAN

Dr. Augustine has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with BioMarin Pharmaceutical and RegenxBio. Dr. Augustine has received research support from Abeona Therapeutics and Biohaven Pharmaceutical .